Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
nmbr1stckpckr's Profile
Displaying 601-650 of 2070 result(s).
CYDY CytoDyn Inc
03/08/2021 11:53:52 PM
It wasn't that the board didn't hav (3)
CYDY CytoDyn Inc
03/08/2021 10:54:57 PM
I think that's just being given an
CYDY CytoDyn Inc
03/08/2021 10:05:50 PM
Has there ever been any science don
CYDY CytoDyn Inc
03/08/2021 8:08:41 PM
Chiro is submitting (or has already
CYDY CytoDyn Inc
03/08/2021 7:26:32 PM
Someone on the panel said there are
CYDY CytoDyn Inc
03/08/2021 1:52:02 PM
And someone might as well link it i (1)
CYDY CytoDyn Inc
03/08/2021 1:23:37 PM
Fine. If the EFFDA is sincerely onl (3)
CYDY CytoDyn Inc
03/08/2021 12:26:58 PM
If he didn't change the test method (1)
CYDY CytoDyn Inc
03/08/2021 10:22:42 AM
You realize that MOST of the volume (12)
CYDY CytoDyn Inc
03/08/2021 1:26:42 AM
I'm gonna guess a trading range tom (3)
CYDY CytoDyn Inc
03/07/2021 9:18:45 PM
This is the PR campaign that NP sai
CYDY CytoDyn Inc
03/07/2021 9:15:53 PM
LOL. As if NP designed the trial??? (10)
CYDY CytoDyn Inc
03/07/2021 5:20:30 PM
I'd say you're more than bummed. ". (2)
CYDY CytoDyn Inc
03/07/2021 4:02:59 PM
This board might have people who ca (1)
CYDY CytoDyn Inc
03/07/2021 3:49:07 PM
While we are all obsessed with the (1)
CYDY CytoDyn Inc
03/07/2021 10:45:43 AM
Only CYDY investors are disappointe (3)
CYDY CytoDyn Inc
03/06/2021 3:21:50 PM
That's what I mean. The news is goo (1)
CYDY CytoDyn Inc
03/06/2021 2:35:59 PM
This board, with a few exceptions, (2)
CYDY CytoDyn Inc
03/06/2021 1:53:43 PM
Yahoo finance too. https://www.goog
CYDY CytoDyn Inc
03/06/2021 12:43:07 PM
Too many on this board are overthin (8)
CYDY CytoDyn Inc
03/06/2021 12:35:30 PM
That's why I say reprioritize. Focu (5)
CYDY CytoDyn Inc
03/06/2021 12:13:46 PM
Its bad news if its bad news. I don (3)
CYDY CytoDyn Inc
03/06/2021 11:14:56 AM
So how fast can CYDY enroll additio (1)
CYDY CytoDyn Inc
03/06/2021 10:50:27 AM
You sure are obsessed with looking (6)
CYDY CytoDyn Inc
03/06/2021 10:41:31 AM
Looks like they unblinded during th (3)
CYDY CytoDyn Inc
03/06/2021 8:02:29 AM
The only reason to not give EUA now (2)
CYDY CytoDyn Inc
03/06/2021 12:19:41 AM
That's funny. I don't see how you c (1)
CYDY CytoDyn Inc
03/05/2021 7:45:34 PM
There are good and bad optimists. T (2)
CYDY CytoDyn Inc
03/05/2021 7:29:09 PM
Gawd, some of you have such underde (5)
CYDY CytoDyn Inc
03/05/2021 6:39:01 PM
I was just saying.
NNLX Nanologix Inc
03/05/2021 5:41:11 PM
Me! Me! I do! I do! At least we'll (1)
CYDY CytoDyn Inc
03/05/2021 5:35:41 PM
Next week? I feel it in my bones...
CYDY CytoDyn Inc
03/05/2021 5:34:31 PM
No, they used what they thought was
CYDY CytoDyn Inc
03/05/2021 1:01:22 AM
Oh yeah! Buy me out. I'm cheap comp (2)
NNLX Nanologix Inc
03/04/2021 4:55:28 PM
Nice to hold NNLX today. Hardly not (1)
CYDY CytoDyn Inc
03/04/2021 1:56:42 PM
Please please please no news today (3)
CYDY CytoDyn Inc
03/04/2021 9:12:56 AM
How dare you. This is Amirrca!
CYDY CytoDyn Inc
03/04/2021 2:33:03 AM
I hope all these SEC filings are in (3)
CYDY CytoDyn Inc
03/04/2021 12:54:45 AM
Still no news? *sigh*
CYDY CytoDyn Inc
03/02/2021 5:02:14 PM
The market is gamed by those with t
CYDY CytoDyn Inc
02/28/2021 7:54:19 PM
I think we skip EUA and they announ
CYDY CytoDyn Inc
02/28/2021 1:41:53 AM
Wtf.... seriously? They're stupidit (3)
NNLX Nanologix Inc
02/26/2021 5:36:05 PM
owning NNLX stock is like owning ot
CYDY CytoDyn Inc
02/26/2021 1:51:10 PM
*yawn* no news yet. back to bed.
CYDY CytoDyn Inc
02/24/2021 11:49:10 PM
I thought about it. I am leaning to (2)
CYDY CytoDyn Inc
02/24/2021 7:53:07 PM
Good day today. Should never have h
CYDY CytoDyn Inc
02/23/2021 3:27:08 AM
EFFDA is simply going thru the chec
CYDY CytoDyn Inc
02/22/2021 6:59:48 PM
So the DSMC (?) are a bunch of idio
CYDY CytoDyn Inc
02/22/2021 6:58:03 PM
Dang, took a hit today. Didn't thin (5)
CYDY CytoDyn Inc
02/22/2021 10:37:33 AM
I'm concerned/confused as to why CY (1)
Go to page:
  • << First
  • < Previous
  • 12
  • 13
  • Next >

Recent Articles

  • Bionano Genomics Unveils Important Findings on T-ALL in Kids
  • Exciting Launch of Brayden Preserve by LGI Homes in North Carolina
  • Fly-E Group Expands to South America with New Store Launch
  • Replimune's Innovative Progress in Immunotherapy Financial Review
  • Natalia Premovic Joins Playboy's Board for Future Growth
  • Prime Medicine's Financial Results Showcase Strong Growth and Progress
  • GCM Grosvenor Reports Strong Q2 2025 Earnings Growth and Insights
  • DarĂ© Bioscience Unveils Financial Insights and Updates Soon
  • Enviri Corporation Showcases Commitment at Investor Events
  • Ascentage Pharma Plans 2025 Mid-Year Results Release and Update
  • Belite Bio's Direct Offering: What Investors Should Know
  • Insightful Position Updates from Rathbones Group Plc
  • Kinetic Seas Unveils Skilliks: A Game-Changer for AI Software Projects
  • Insights on Apax Global Alpha Limited's Disclosure Position
  • Rathbones Group Plc Reveals Financial Interests in Assura Plc
  • Breadboard Welcomes Nemanja Jokanovic as New Sales VP
  • Victoria's Secret & Co. Announces Upcoming Earnings Call Webcast
  • Trump's New Tariffs: Economic Strategy or Potential Downfall?
  • Genie Energy Reports Strong Q2 2025 Growth and Challenges
  • Transforming Clarence Square: A Green Haven in Downtown
  • Cars.com: Impressive Growth Report for Q2 2025
  • Exciting Enhancements to Clarence Square Park: A Green Oasis
  • Nova Ltd. Delivers Record Financial Results in Second Quarter
  • Join AI Prop's Exciting Global Raffle for Dubai Experience!
  • TEGNA Inc. Delivers Q2 2025 Earnings and Strategic Insights
  • WhiteHorse Finance Reports Q2 Earnings and Confident Outlook
  • Daxor's FDA-Approved Blood Volume Analyzer Revolutionizes Care
  • Sabre Corporation's Strong Q2 2025 Earnings Release Overview
  • FleishmanHillard Elevates Leadership for Global Corporate Affairs
  • Insights from 3 E Network CEO Dr. Yang on Digital Assets
  • Fidelity National Financial Declares Latest Dividend Payment
  • Collegium Pharmaceutical: Second Quarter 2025 Financial Highlights
  • Suburban Propane Partners Reveals Challenges and Insights
  • Cassava Sciences Welcomes Dr. Hulihan as New CMO for Growth
  • MACOM Technology Solutions Achieves Remarkable Q3 Financial Growth
  • F&G Annuities & Life Announces Quarterly Dividend Payments
  • Knight Therapeutics Enhances Growth and Financial Position
  • Innovative AI+ Solutions Drive Technological Growth and Collaboration
  • illumin Holdings Reports Impressive Q2 2025 Financial Growth
  • Jacobs Secures Contract for Rail Upgrades at Major Port Facility
  • Palvella Therapeutics Discusses Q2 2025 Financial Outcomes
  • Knight Therapeutics' Q2 2025 Financial Success and Updates
  • EverBank's Bold Move with New Subordinated Notes Offering
  • Chris Layden Steps in as Kelly Services’ New CEO
  • Portland General Electric Launches 475 MW Battery Systems
  • Cassava Sciences Welcomes Dr. Joseph Hulihan as CMO
  • Y-mAbs Therapeutics Prepares to Share Q2 2025 Insights
  • Assessing India's Economic Risk Amid US Tariff Challenges
  • Kelly Appoints Chris Layden as New CEO to Drive Growth
  • illumin Holdings Inc. Reports Impressive Q2 Performance
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site